Fig. 2
From: In vitro drug testing using patient-derived ovarian cancer organoids
Patient-derived organoids morphologically and molecularly matched the parent tumors. H&E stain and immunohistochemistry of PDOs in HGSC (HGSC-5, A) and mucinous ovarian cancer (MC-4, B) in paired tumor (upper), OV-PDOs (middle), and database (lower)